Life Tech to Distribute Aruna Cell Products | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies will distribute Aruna Biomedical's human embryonic stem cell-derived neural products, under a non-exclusive, multi-year agreement announced today by Athens, Ga.-based Aruna.

Aruna said that Life Technologies will provide the neural products and will be able to provide customized screening services using Aruna products and technologies. The firm said that other human cellular products may be added to the pact in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.